Market Overview
The Immunohistochemistry market report is predicted to develop at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2034, when global Immunohistochemistry market forecast size is projected to reach USD 7.95 Billion in 2034, based on an average growth pattern. The global Immunohistochemistry market revenue is estimated to reach a value of USD 3.68 Billion in 2024.
SOURCE: We Market Research
Immunohistochemistry
(IHC) is a laboratory technique used to detect specific proteins or antigens in
tissue samples using antibodies. The process involves staining tissues with
antibodies that bind specifically to the target proteins, allowing researchers
or pathologists to visualize where these proteins are located within the tissue
under a microscope.
IHC is widely
used in pathology labs to help diagnose diseases, especially cancers. It can
identify specific proteins that indicate the presence or type of cancer,
helping guide treatment decisions.
In the life
sciences, IHC is used to study the expression of proteins in different tissues,
track the progression of diseases, and understand cellular functions.
The global
immunohistochemistry (IHC) market refers to the market for technologies,
products, and services related to the detection and visualization of specific
proteins or antigens in tissue samples using antibodies. IHC is widely used in
clinical diagnostics, medical research, drug development, and biotechnology to
study disease mechanisms, identify biomarkers, and guide treatment decisions. The
global immunohistochemistry (IHC) market has been experiencing significant
growth, driven by advancements in diagnostics, increasing prevalence of chronic
diseases, and the demand for personalized medicine. Immunohistochemistry is a
technique used in the diagnosis of diseases, particularly cancers, by detecting
specific antigens in cells of a tissue section.
Global Immunohistochemistry Market Scope
Report Attributes |
Description |
Market Size in 2024 |
USD 3.68 Billion |
Market
Forecast in 2034 |
USD 7.95 Billion |
CAGR % 2024-2034 |
7.5% |
Base
Year |
2023 |
Historic Data |
2016-2022 |
Forecast
Period |
2024-2034 |
Report USP
|
Production,
Consumption, company share, company heatmap, company production capacity,
growth factors and more |
Segments
Covered |
By Product, By
Application, By End-use and By Region |
Regional Scope |
North America,
Europe, APAC, South America and Middle East and Africa |
Country
Scope |
U.S.; Canada;
U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia;
China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico;
Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Market Dynamics & Restraints
Global Immunohistochemistry Market Opportunity:
We Market
Research: Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into global Immunohistochemistry market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Immunohistochemistry Market Segmentation
Market- By Product Analysis
By product, the Immunohistochemistry market share is categories into Antibodies, Equipment, Reagents and Kits. Antibodies dominates the market with the largest share, accounting for over 50% of the market in 2023. The high demand for antibodies is primarily due to their critical role in detecting specific antigens in tissue samples. They are extensively used in cancer diagnostics, biomarker studies, and research applications.
The
following segments are part of an in-depth analysis of the global Immunohistochemistry
market:
Market Segments |
|
By Product |
·
Antibodies o
Primary Antibodies o
Secondary Antibodies ·
Equipment o
Slide Staining System o
Tissue Microarrays o
Tissue Processing Systems o
Slide Scanners o
Others ·
Reagents o
Histological stains o
Blocking Sera and Reagents o
Chromogenic Substrates o
Fixation Reagents o
Stabilizers o
Organic Solvents o
Proteolytic Enzymes o
Diluents ·
Kits |
By Application |
·
Diagnostics o
Cancer o
Infectious Diseases o
Cardiovascular Diseases o
Autoimmune Diseases o
Diabetes Mellitus o
Nephrological Diseases ·
Research ·
Drug Development and Discovery |
By End-use |
·
Hospitals & Diagnostic Laboratories ·
Research Institutes ·
Others |
Immunohistochemistry Industry: Regional Analysis
North America Market Forecast
North America dominates the global market, accounting for around 38% of the market share in 2023. The dominance of this region is driven by the presence of leading market players, high adoption of advanced diagnostic techniques, well-established healthcare infrastructure, and a significant focus on cancer research and personalized medicine. The United States is the largest contributor to the market in this region, followed by Canada.
Europe Market Statistics
Factors such as
the rising prevalence of chronic diseases, increased healthcare spending, and
strong emphasis on research and development in countries like Germany, France,
and the UK are fueling the market growth in this region. The presence of
favorable regulatory guidelines and reimbursement policies also supports the
expansion of the IHC market in Europe.
Asia Pacific Market Forecasts
The growth in
this region is driven by increasing investments in healthcare infrastructure,
rising awareness about early cancer detection, and the growing demand for
personalized medicine. Countries like China, India, Japan, and South Korea are
leading contributors to the regional market. The increasing number of
biotechnology and pharmaceutical companies, coupled with the availability of a
large patient pool, is creating lucrative opportunities for the market's growth
in this region.
Middle East & Africa Market Statistics
The market in
this region is growing steadily, mainly due to increasing government
initiatives to improve healthcare infrastructure and rising awareness about
cancer diagnostics. Countries like South Africa, Saudi Arabia, and the UAE are
significant contributors to the market. Factors like limited access to
healthcare services, economic constraints, and low adoption of advanced
diagnostic technologies are restricting the market growth in this region.
Latin America Market Statistics
The growing
incidence of cancer and other chronic diseases, along with improving healthcare
facilities in countries like Brazil, Mexico, and Argentina, is driving the
market growth in this region.
The Immunohistochemistry Market
is dominated by a few large companies, such as
·
F. Hoffmann-La Roche Ltd
·
Agilent Technologies, Inc.
·
Danaher Corporation (Leica
Biosystems)
·
Thermo Fisher Scientific Inc.
·
Merck KGaA (MilliporeSigma)
·
Bio-Rad Laboratories, Inc.
·
Abcam plc
·
Biocare Medical, LLC
·
Cell Signaling Technology, Inc.
(CST)
·
PerkinElmer Inc.
·
Sakura Finetek Japan Co., Ltd.
· Becton, Dickinson and Company (BD)
1.
Global
Immunohistochemistry Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Immunohistochemistry
Market Scope and Market Estimation
1.2.1. Global Immunohistochemistry Overall
Market Size (US$ Bn), Market CAGR (%), Market forecast (2024 - 2034)
1.2.2. Global Immunohistochemistry
Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3. Market Segmentation
1.3.1. Product of Global Immunohistochemistry
Market
1.3.2. Ventilation Mode of Global Immunohistochemistry
Market
1.3.3. End-use of Global Immunohistochemistry
Market
1.3.4. Region of Global Immunohistochemistry
Market
2.
Executive Summary
2.1. Demand Side Trends
2.2. Key Market Trends
2.3. Market Demand (US$ Bn) Analysis
2019 – 2023 and Forecast, 2024 – 2034
2.4. Demand and Opportunity
Assessment
2.5. Demand Supply Scenario
2.6. Market Dynamics
2.6.1. Drivers
2.6.2. Limitations
2.6.3. Opportunities
2.6.4. Impact Analysis of Drivers and
Restraints
2.7. Pricing Trends Analysis
2.8. Overview of Technology Developments
2.9. Porter’s Five Forces Analysis
2.9.1. Bargaining Power of Suppliers
2.9.2. Bargaining Power of Buyers
2.9.3. Threat of Substitutes
2.9.4. Threat of New Entrants
2.9.5. Competitive Rivalry
2.10. PEST Analysis
2.10.1. Political Factors
2.10.2. Economic Factors
2.10.3. Social Factors
2.10.4. Technology Factors
2.11. Value Chain / Ecosystem Analysis
2.12. Key Regulation
3.
Global Immunohistochemistry
Market Estimates & Historical Trend
Analysis (2019 - 2023)
4.
Global Immunohistochemistry
Market Estimates & Forecast Trend
Analysis, by Product
4.1. Global Immunohistochemistry
Market Revenue (US$ Bn) Estimates and Forecasts, by Product, 2019 - 2034
4.1.1. Critical care
4.1.1.1.
Ventilators
4.1.1.2.
Accessories
4.1.2. Neonatal
4.1.2.1.
Ventilators
4.1.2.2.
Accessories
4.1.3. Transport & portable
4.1.3.1.
Ventilators
4.1.3.2.
Accessories
4.1.4. Other
5.
Global Immunohistochemistry
Market Estimates & Forecast Trend
Analysis, by Ventilation Mode
5.1. Global Immunohistochemistry
Market Revenue (US$ Bn) Estimates and Forecasts, by Ventilation Mode, 2019 -
2034
5.1.1.Invasive
5.1.2.Non-invasive
5.1.2.1.
CPAP
5.1.2.2.
BiPAP
5.1.2.3.
Others
6.
Global Immunohistochemistry
Market Estimates & Forecast Trend
Analysis, by End-use
6.1. Global Immunohistochemistry
Market Revenue (US$ Bn) Estimates and Forecasts, by End-use, 2019 - 2034
6.1.1.Hospitals
6.1.2.Home
healthcare
6.1.3.Ambulatory
Surgical Centers
6.1.4.Others
7.
Global Immunohistochemistry
Market Estimates & Forecast Trend
Analysis, by Region
7.1. Global Immunohistochemistry
Market Revenue (US$ Bn) Estimates and Forecasts, by Region, 2019 - 2034
7.1.1. North America
7.1.2. Eastern Europe
7.1.3. Western Europe
7.1.4. Asia Pacific
7.1.5. Middle East & Africa
7.1.6. Latin America
8.
North
America Immunohistochemistry Market: Estimates & Forecast Trend Analysis
8.1.
North
America Immunohistochemistry Market Assessments & Key Findings
8.1.1. North America Immunohistochemistry
Market Introduction
8.1.2. North America Immunohistochemistry
Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
8.1.2.1. By Product
8.1.2.2. By Ventilation Mode
8.1.2.3. By End-use
8.1.2.4. By Country
8.1.2.4.1. The U.S.
8.1.2.4.2. Canada
8.1.2.4.3. Mexico
9.
Western
Europe Immunohistochemistry Market: Estimates & Forecast Trend Analysis
9.1. Western Europe Immunohistochemistry
Market Assessments & Key Findings
9.1.1. Western Europe Immunohistochemistry
Market Introduction
9.1.2. Western Europe Immunohistochemistry
Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
9.1.2.1. By Product
9.1.2.2. By Ventilation Mode
9.1.2.3. By End-use
9.1.2.4.
By
Country
9.1.2.4.1.
Germany
9.1.2.4.2.
Italy
9.1.2.4.3.
U.K.
9.1.2.4.4.
France
9.1.2.4.5.
Spain
9.1.2.4.6.
Benelux
9.1.2.4.7.
Nordics
9.1.2.4.8. Rest
of W. Europe
10. Eastern Europe Immunohistochemistry
Market: Estimates & Forecast Trend
Analysis
10.1. Eastern Europe Immunohistochemistry
Market Assessments & Key Findings
10.1.1. Eastern Europe Immunohistochemistry
Market Introduction
10.1.2. Eastern Europe Immunohistochemistry
Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
10.1.2.1. By Product
10.1.2.2. By Ventilation Mode
10.1.2.3. By End-use
10.1.2.4. By Country
10.1.2.4.1.
Russia
10.1.2.4.2.
Hungary
10.1.2.4.3.
Poland
10.1.2.4.4.
Balkan & Baltics
10.1.2.4.5. Rest of E. Europe
11. Asia Pacific Immunohistochemistry
Market: Estimates & Forecast Trend
Analysis
11.1. Asia Pacific Market Assessments
& Key Findings
11.1.1. Asia Pacific Immunohistochemistry
Market Introduction
11.1.2. Asia Pacific Immunohistochemistry
Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
11.1.2.1. By Product
11.1.2.2. By Ventilation Mode
11.1.2.3. By End-use
11.1.2.4. By Country
11.1.2.4.1. China
11.1.2.4.2. Japan
11.1.2.4.3. India
11.1.2.4.4. Australia & New Zealand
11.1.2.4.5. South Korea
11.1.2.4.6. ASEAN
11.1.2.4.7. Rest of Asia Pacific
12. Middle East & Africa Immunohistochemistry
Market: Estimates & Forecast Trend
Analysis
12.1. Middle East & Africa Market
Assessments & Key Findings
12.1.1. Middle
East & Africa Immunohistochemistry
Market Introduction
12.1.2. Middle
East & Africa Immunohistochemistry
Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
12.1.2.1. By Product
12.1.2.2. By Ventilation Mode
12.1.2.3. By End-use
12.1.2.4. By Country
12.1.2.4.1. UAE
12.1.2.4.2. Saudi
Arabia
12.1.2.4.3. Turkey
12.1.2.4.4. South
Africa
12.1.2.4.5. Rest of
MEA
13. Latin America
Immunohistochemistry Market: Estimates
& Forecast Trend Analysis
13.1. Latin America Market Assessments
& Key Findings
13.1.1. Latin America Immunohistochemistry
Market Introduction
13.1.2. Latin America Immunohistochemistry
Market Size Estimates and Forecast (US$ Billion) (2019 - 2034)
13.1.2.1. By Product
13.1.2.2. By Ventilation Mode
13.1.2.3. By End-use
13.1.2.4. By Country
13.1.2.4.1. Brazil
13.1.2.4.2. Argentina
13.1.2.4.3. Colombia
13.1.2.4.4. Rest of
LATAM
14. Country Wise Market:
Introduction
15. Competition Landscape
15.1. Global Immunohistochemistry
Market Product Mapping
15.2. Global Immunohistochemistry Market
Concentration Analysis, by Leading Players / Innovators / Emerging Players /
New Entrants
15.3. Global Immunohistochemistry
Market Tier Structure Analysis
15.4. Global Immunohistochemistry
Market Concentration & Company Market Shares (%) Analysis, 2023
16. Company Profiles
16.1. Medtronic plc
16.1.1. Company Overview & Key Stats
16.1.2. Financial Performance & KPIs
16.1.3. Product Portfolio
16.1.4. SWOT Analysis
16.1.5. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
16.2. GE Healthcare
16.3. Koninklijke Philips
N.V.
16.4. ResMed Inc.
16.5. Drägerwerk AG &
Co. KGaA
16.6. Hamilton Medical AG
16.7. Getinge AB
16.8. Vyaire Medical Inc.
16.9. Fisher & Paykel
Healthcare Limited
16.10. Allied Healthcare
Products, Inc.
16.11. Zoll Medical
Corporation
16.12. Becton, Dickinson
and Company (BD)
16.13. Teleflex
Incorporated
16.14. Mindray Medical
International Limited
16.15. Nihon Kohden
Corporation
16.16. WEINMANN Emergency
Medical Technology GmbH + Co. KG
16.17. Air Liquide
Healthcare
16.18. Trivitron
Healthcare
16.19. Others
17. Research
Methodology
17.1. External Transportations /
Databases
17.2. Internal Proprietary Database
17.3. Primary Research
17.4. Secondary Research
17.5. Assumptions
17.6. Limitations
17.7. Report FAQs
18. Research
Findings & Conclusion
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Immunohistochemistry Market was valued at USD 3.68 Billion in 2024.
Immunohistochemistry Market size will increase at approximate CAGR of 7.5% during the forecasted period.
Major companies operating within the market are F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Danaher Corporation (Leica Biosystems), Thermo Fisher Scientific Inc., Merck KGaA (MilliporeSigma), Bio-Rad Laboratories, Inc., Abcam plc, Biocare Medical, LLC, Cell Signaling Technology, Inc. (CST), PerkinElmer Inc., Sakura Finetek Japan Co., Ltd., Becton, Dickinson and Company (BD) and others.
North America dominates the market with an active share of 38%.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar